| Literature DB >> 30206435 |
Şeyma Şeniz Ersöz1, Serap Coşansu1.
Abstract
The concern about the possibility of food can be a vehicle for the transmission of Clostridium difficile to humans has been raised recently due to the similarities among the strains isolated from patients, foods and food animals. In this study, therefore, the prevalence of C. difficile was investigated in beef and chicken meat products collected from 57 different butcher shops, markets and fast food restaurants in Sakarya province of Turkey. Two out of 101 samples (1.98%) was positive for C. difficile indicating a very low prevalence. The pathogen was isolated from an uncooked meatball sample and a cooked meat döner sample, whereas not detected in chicken meat samples. The meatball isolate was resistant to vancomycin and tetracycline, while the cooked meat döner isolate was resistant to vancomycin and metronidazole. Both isolates were sensitive to moxifloxacin and clindamycin. Toxins A and B were not detected. This study reveals the presence of C. difficile in further processed beef products in Turkey.Entities:
Keywords: Clostridium difficile; antibiotic resistance; beef; chicken; meat
Year: 2018 PMID: 30206435 PMCID: PMC6131381 DOI: 10.5851/kosfa.2018.e14
Source DB: PubMed Journal: Korean J Food Sci Anim Resour ISSN: 1225-8563 Impact factor: 2.622
Results of identification with API20A
| Identification result | Number of isolates |
|---|---|
| 2 | |
| 9 | |
| 3 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| Non- | 13 |
| Unidentified | 18 |
| Total | 52 |
Prevalence of Clostridium difficile in beef and chicken meat products
| Sample type | Number of samples collected | Number of |
|---|---|---|
| Ground beef | 31 | 0 |
| Chicken breast | 27 | 0 |
| Meat ball | 18 | 1 |
| Cooked meat döner | 12 | 1 |
| Cooked chicken döner | 7 | 0 |
| Salami | 4 | 0 |
| Frankfurter | 1 | 0 |
| Bacon | 1 | 0 |
| Total | 101 | 2 (1.98%) |
MIC values of antibiotics for Clostridium difficile isolates by E-test
| Antibiotics | MIC breakpoints (µg/mL) | MIC values of | ||||
|---|---|---|---|---|---|---|
| S | I | R | MB025 | ED046 | ||
| Metronidazole[ | >8 | 16 | >256 | 0.125 | >256 | |
| Moxifloxacin[ | >2 | 4 | >8 | 0.75 | 0.38 | |
| Tetracycline[ | >4 | 8 | >16 | 48 | 0.047 | |
| Clindamycin[ | >2 | 4 | >8 | 0.6 | 0.19 | |
| Vancomycin[ | >2 | - | >2 | >256 | 4 | |
1) The breakpoints defined by Clinical and Laboratory Standards Institute (CLSI).
2) The breakpoints defined by European Committee for Antimicrobial Susceptibility Testing (EUCAST).
MIC, minimum inhibition concentration; S, susceptible; I, intermediate; R, resistant.